Retinoic Acid-Induced Neuritogenesis of Human Neuroblastoma SH-SY5Y Cells Is ERK Independent and PKC Dependent

Journal of Neuroscience Research

Volumn 75, Issue 2, 2004, Pages 241-252

  Miloso, Mariarosaria ^a,c   Villa, Daniela ^a   Crimi, Marco ^b   Galbiati, Stefania ^a   Donzelli, Elisabetta ^a   Nicolini, Gabriella ^a   Tredici, Giovanni ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cell survival; ERK signaling pathway; Neuronal differentiation; PI 3 K; PKC inhibitor

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ENZYME INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; RAF PROTEIN; RETINOIC ACID; WORTMANNIN;

CELL DIFFERENTIATION; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; ENZYMOLOGY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; METABOLISM; NERVE FIBER GROWTH; NERVOUS SYSTEM; NEURITE; NEUROBLASTOMA; PHOSPHORYLATION; PHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TUMOR CELL; TUMOR CELL LINE; ULTRASTRUCTURE;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NERVOUS SYSTEM; NEURITES; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; TRETINOIN;

EID: 0347360088     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10848     Document Type: Short Survey

References (55)

1. Chambon P. 1994. The retinoid signaling pathway: molecular and genetic analysis. Semin Cell Biol. 5:115-125.
2. Chou MM, Hou W, Johnson J, Graham LK, Lee MH, Chen CS, Newton AC, Schaffhausen BS, Toker A. 1998. Regulation of protein kinase C zeta by PI 3-kinase and PDK-1. Curr Biol 8:1069-1077.
3. Corbit KC, Foster DA, Rosner MR. 1999. Protein kinase Cδ mediates neurogenic but not mitogenic activation of mitogen-activated protein kinase in neuronal cells. Mol Cell Biol 19:4209-4218.
4. Corbit KC, Soh JW, Yoshida K, Eves EM, Weinstein IB, Rosner MR. 2000. Different protein kinase C isoforms determine growth factor specificity in neuronal cells. Mol Cell Biol 20:5392-5403.
5. Crimi M, Di Silvestro A, Galbiati S, Nicolini G, Miloso M. 1999. Retinoid acid-induced extracellular signal regulated kinase (ERK) phosphorylation is not required for neurite outgrowth of human neuroblastoma SH-SY5Y cells. Ital J Anat Embryol 104:172.
6. Duckworth BC, Cantley LC. 1997. Conditional inhibition of the mitogen-activated protein kinase cascade by wortmannin. Dependence on signal strength. J Biol Chem 272:27665-27670.
7. Enarsson M, Erlandsson A, Larsson H, Forsberg-Nilsson K. 2002. Extracellular signal-regulated protein kinase signaling is uncoupled from initial differentiation of central nervous system stem cells to neurons. Mol Cancer Res 1:147-154.
8. Encinas M, Iglesia M, Liu Y, Muhaisen A, Ceǹa V, Gallego C, Comella JX. 2000. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75:991-1003.
9. Encinas M, Iglesias M, Llecha N, Comella JX. 1999. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuro-blastoma cell line SH-SY5Y. J Neurochem 73:1409-1421.
10. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, Copeland RA, Magolda RL, Scherle PA, Trzaskos JM. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 273:18623-18632.
11. Ferby IM, Waga I, Sakanaka C, Kume K, Shimizu T. 1994. Wortmannin inhibits mitogen-activated protein kinase activation induced by platelet-activating factor in guinea pig neutrophils. J Biol Chem 269:30485-30488.
12. ras in PC12 cells. J Neurochem 74:92-98.
13. Hoyos B, Imam A, Chua R, Swenson C, Tong GX, Levi E, Noy N, Hämmerling U. 2000. The cysteine-rich regions of the regulatory domains of Raf and protein kinase C as retinoid receptors. J Exp Med 192:835-845.
14. Kim B, Leventhal PS, Saltiel AR, Feldman EL. 1997. Insulin-like growth factor-1-mediated neurite outgrowth in vitro requires mitogen-activated protein kinase activation. J Biol Chem 272:21268-21273.
15. Klinz FJ, Wolff P, Heumann R. 1996. Nerve growth factor-stimulated mitogen-activated protein kinase activity is not necessary for neurite outgrowth of chick dorsal root ganglion sensory and sympathetic neurons. J Neurosci Res 46:720-726.
16. Kolch W. 2000. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J 351:289-305.
17. Kuo WL, Chung KC, Rosner MR. 1997. Differentiation of central nervous system neuronal cells by fibroblast-derived growth factor requires at least two signaling pathways: role for Ras and Src. Mol Cell Biol 17:4633-4643.
18. Lefebvre O, Wouters D, Mereau-Richard C, Facon T, Zandecki M, Formstecher P, Belin MT. 1999. Induction of apoptosis by all-trans retinoic acid in the human myeloma cell line RPMI 8226 and negative regulation of some of its typical morphological features by dexamerbasone. Cell Death Differ 6:433-444.
19. Le Good JA, Ziegler WH, Parekh DB, Alessi RD, Cohen P, Parker PJ. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042-2045.
20. López-Carballo G, Moreno L, Masiá S, Pérez P, Barettino D. 2002. Activation of the phosphatidylinositol 3-kinase/Akt signaling pathway by retinoic acid is required for neutral differentiation of SH-SY5Y human neuroblastoma cells. J Biol Chem 277:25297-25304.
21. Maden M, Holder N. 2002. Retinoic acid and development of the central nervous system. Bioessays 14:431-438.
22. Marra F, Pinzani M, DeFranco R, Laffi G, Gentilini P. 1995. Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett 376:141-145.
23. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
24. McCaffery P, Dräger UC. 2000. Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor. Cytokine Growth Factor Rev 11:233-249.
25. Miloso M, Mazzotti M, Vass WC, Beguinot L. 1995. SHC and GRB-2 are constitutively activated by an epidermal growth factor receptor with a point mutation in a transmembrane domain. J Biol Chem 270:19557-19562.
26. Monick MM, Carter AB, Flaherty DM, Peterson MW, Hunninghake GW. 2000. Protein kinase Cζ plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J Immunol. 165:4632-4639.
27. Neri LM, Marchisio M, Colamussi ML, Bertagnolo V. 1999. Monocytic differentiation of HL-60 cells is characterized by the nuclear translocation of phosphatidylinositol 3-kinase and of definite phosphatidylinositol-specific phospholipase C isoform. Biochem Biophys Res Commun 259:314-320.
28. Nicolini G, Miloso M, Zoia C, Di Silvestro A, Cavaletti G, Tredici G. 1998. Retinoic acid differentiated SH-SY5Y human neuroblastoma cells: an in vitro model to assess drug neurotoxicity. Anticancer Res 18:2477-2482.
29. Nicolini G, Rigolio R, Seuteri A, Miloso M, Saccomanno D, Cavaletti G, Tredici G. 2003. Effect of trans-resveratrol on signal transduction pathways involved in paclitaxel-induced apoptosis in human neuroblastoma SH-SY5Y cells. Neurochem Int 42:419-429.
30. Olsson AK, Nanberg E. 2001. A functional role for ERK in gene induction, but not in neurite outgrowth in differentiating neuroblastoma cells. Exp Cell Res 265:21-30.
31. Olsson AK, Vadhammar K, Nanberg E. 2000. Activation and protein kinase C-dependent nuclear accumulation of ERK in differentiating human neuroblastoma cells. Exp Cell Res 256:454-467.
32. Pahlman S, Hochner JC, Nanberg E, Hedborg F, Fagerstrom S, Gestblom C, Johansson I, Larsson U, Lavenius E, Ortoft E, Soderholm H. 1995. Differentiation and survival influences of growth factors in human neuroblastoma. Eur J Cancer 31:453-458.
33. Pang L, Sawada T, Decker SJ, Saltiel AR. 1995. Inhibition of MAP kinase kinase blocks the differentiation of PC12 cells induced by nerve growth factor. J Biol Chem 270:13585-13588.
34. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel R, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ. 1994. Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54:2419-2423.
35. Reynolds CP. 2000. Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Curr Oncol Rep 2:511-518.
36. Ross RA, Spengler BA, Biedler JL. 1983. Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-749.
37. Sajan MP, Standaert ML, Bandyopadhyay G, Quon MJ, Burke TR, Farese RV. 1999. Protein kinase Cζ and phosphoinositide-dependent protein kinase-I are required for insulin-induced activation of ERK in rat adipocytes. J Biol Chem 274:30495-30500.
38. Schaeffer HJ, Weber MJ. 1999. Mitogen-activated protein kinases: specific messages from ubiquitous messengers. Mol Cell Biol 19:2435-2444.
39. Schönwasser DC, Marais RM, Marshall CJ, Parker PJ. 1998. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol Cell Biol 18:790-798.
40. Sidell N, Altman A, Haussler MR, Seeger RC. 1983. Effect of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines. Exp Cell Res 148:21-30.
41. Singh US, Pan J, Kao YL, Joshi S, Young KL, Baker KM. 2003. Tissue transglutaminase mediates activation of RhoA and MAP kinase pathways during retinoic-acid induced neuronal differentiation of SH-SY5Y cells. J Biol Chem 278:391-399.
42. Sun SY, Lotan R. 2002. Retinoids and their receptors in cancer development and chemoprevention. Crit Rev Oncol Hematol 41:41-55.
43. Svendsen CN, Smith AG. 1999. New prospects for human stem-cell therapy in the nervous system. Trends Neurosci 22:357-364.
44. Sweatt JD. 2001. The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory. J Neurochem 76:1-10.
45. Tallman MS, Nabhan C, Feusner JH, Rowe JM. 2002. Acute promyelocytic leukemia: evolving therapeutic strategies. Blood 99:759-767.
46. Toullec D, Pianetti P, Coste H, Bellevergue P, Grand-Perret T, Ajakane M, Baudet V, Boissin P, Boursier E, Loriolle F, Duhamel L, Charon D, Kirilovsky J. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J Biol Chem 266:15771-15781.
47. Traverse S, Gomez N, Paterson H, Marshall C, Cohen P. 1992. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Biochem J 288:351-355.
48. Tredici G, Petruccioli MG, Tarelli LT, Cece R, Pizzini G. 1995. Ultrastructural and confocal laser scanning microscopical aspects of apoptosis in cultured human neuroblastoma SH-SY5Y cells. Ital J Anat Embryol 100:47-53.
49. Treisman R. 1996. Regulation of transcription by MAP kinase cascade. Curr Opin Cell Biol 8:205-215.
50. Uberall F, Hellbert K, Kampfer S, Maly K, Villunger A, Spitaler M, Mwanjewe J, Baier-Bitterlich G, Baier G, Grunicke HH. 1999. Evidence that atypical protein kinase C-λ and atypical protein kinase C-ζ participate in Ras-mediated reorganization of the F-actin cytoskeleton. J Cell Biol 144:413-425.
51. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, Ohno S. 1996. Protein kinase Cδ activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271:23512-23519.
52. Widmann C, Gibson S, Jarpe MB, Johnson GL. 1999. Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol Rev 79:143-180.
53. Yen A, Roberson MS, Varvayanis, S, Lee AT. 1998. Retinoic-acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58:3163-3172.
54. Zeidman R, Petterson L, Sailaja PR, Truedsson E, Fagerström S, Pahlman S, Larsson C. 1999. Novel and classical protein kinase C isoforms have different functions in proliferation, survival and differentiation of neuroblastoma cells. Int J Cancer 81:494-501.
55. Zhang BH, Guan KL. 2000. Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601. EMBO J 19:5429-5439.